The Longevity Genes in Founder Populations Project
Part of paid clinical trials in New York, New York.
- Sponsor
- Albert Einstein College of Medicine
- Study ID
- NCT00707694
- Status
- Recruiting
Conditions
- Extreme Longevity
Eligibility Criteria
- Sex
- ALL
- Age
- 65 Years - N/A
- Healthy Volunteers
- Accepted
Study Details
We believe extreme longevity is due to specific genes which function to delay aging and prevent disease. The purpose of the research is to identify the genes/mutations associated with healthier aging; to understand the biological functions of these genes/mutations; and to develop therapies to replicate these preservative genetic activities in individuals who do not have the genetic profile for longevity.
Key Dates
- Start date
- Jul 31, 1998
- Status verified
- Dec 2025
- Primary completion
- Dec 31, 2032
- Completion
- Dec 31, 2032
Study Design
- Enrollment
- 2,000 participants (estimated)
Arms
- Arm: ProbandsAshkenazi Jews ages 95 and older
- Arm: OffspringAshkenazi Jewish offspring of Ashkenazi Jewish parent(s) who lived to at least the age of 95
- Arm: ControlsAshkenazi Jewish people with no family history of longevity
Central Contacts
- Tina Gao718-839-7176
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Private Homes | New York | New York | - | |
| Hebrew Home Riverdale | Riverdale | New York | 10471 | Charlotte Dell, LMSW 718-581-1139 |
Find similar trials in New York, NY
By research site